Abciximab-induced thrombocytopenia: management of bleeding in the setting of recent coronary stents.

Abciximab-induced thrombocytopenia: management of bleeding in the setting of recent coronary stents. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Abciximab-induced thrombocytopenia: management of bleeding in the setting of recent coronary stents. Abstract Text:

Kris Nowakowski,James Rogers,Gregory Nelson,Brendan Gunalingam,

This case report and subsequent literature review describes the management difficulties in a patient who developed abciximab-induced thrombocytopenia and gastrointestinal bleeding. Abciximab was used to treat the no-reflow phenomenon, which occurred during insertion of three sequential Taxus coronary artery stents. Resuscitation of this bleeding patient with fluids, blood, and platelet transfusion, and the cessation of antiplatelet agents, was complicated by acute stent thrombosis. We discuss the risk factors for stent thrombosis and discuss abciximab-induced thrombocytopenia, looking at its incidence, pathophysiology, differential diagnosis, investigation, course, management, preventative strategies, and prognostic implications.

Abciximab-induced thrombocytopenia: management of bleeding in the setting of recent coronary stents. Publishing Authors By Initials

K Nowakowski,J Rogers,G Nelson,B Gunalingam,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Abciximab-induced thrombocytopenia: management of bleeding in the setting of recent coronary stents. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of interventional cardiology

VOLUME: 21

Page Numbers: 100-5

Journal Abbreviation:

ISSN: 0896-4327

DAY: 13

MONTH: 01

YEAR: 2008

Abciximab-induced thrombocytopenia: management of bleeding in the setting of recent coronary stents. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8907826

Abciximab-induced thrombocytopenia: management of bleeding in the setting of recent coronary stents. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Abciximab-induced thrombocytopenia: management of bleeding in the setting of recent coronary stents. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Abciximab-induced thrombocytopenia: management of bleeding in the setting of recent coronary stents.

AFFILIATION: Departments of Cardiology, Gosford and Royal North Shore Hospitals, New South Wales, Australia.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Interv Cardiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Abciximab-induced thrombocytopenia: management of bleeding in the setting of recent coronary stents Related Publications

• Abciximab-induced thrombocytopenia: management of bleeding in the setting of recent coronary stents.
• Coronary artery aneurysms associated with a Paclitaxel coated stent.
• Retrograde application of the buddy wire technique.